Anti-tumor effect in anin vivomodel by human-derived pancreatic RNase with basic fibroblast growth factor insertional fusion protein through antiangiogenic properties-Reference-Cited by-同舟云学术

Anti-tumor effect in anin vivomodel by human-derived pancreatic RNase with basic fibroblast growth factor insertional fusion protein through antiangiogenic properties

Published:2006-10-09 Issue:12 Volume:97 Page:1315-1320
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Yagi Hiroshi,Ueda Masakazu,Jinno Hiromitsu,Aiura Koichi,Mikami Shuji,Tada Hiroko,Seno Masaharu,Yamada Hidenori,Kitajima Masaki

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2006.00336.x/fullpdf

Reference45 articles.

1. Mitotoxins: growth factor-targeted cytotoxic molecules;Lappi;Prog Growth Factor Res,1990

2. Immunotoxins for targeted cancer therapy;Pastan;Adv Drug Deliv Rev,1998

3. New perspectives in clinical oncology from angiogenesis research;Folkman;Eur J Cancer,1996

4. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis;Hanahan;Cell,1996

5. Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models;Hanahan;Eur J Cancer,1996

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial Ribonuclease 1 in Cardiovascular and Systemic Inflammation;Frontiers in Cell and Developmental Biology;2020-09-04

2. Ribonucleases of different origins with a wide spectrum of medicinal applications;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2011-01

3. Evasion of Ribonuclease Inhibitor as a Determinant of Ribonuclease Cytotoxicity;Current Pharmaceutical Biotechnology;2008-06-01